Mathematical model of endothelial cell proliferation and maturation | Bajger | Mathematica Applicanda

Vol 46, No 1 (2018) , 3-12

Mathematical model of endothelial cell proliferation and maturation

Piotr Bajger, Mariusz Bodzioch

Digital Object Identifier (DOI): 10.14708/ma.v46i1.6383

Abstract

Blood vessel sprouting (angiogenesis) is one of the hallmarks of cancer. Better quantitative understanding of this process would allow more effective antiangiogenic therapies to be developed. It has been hypothesised that not only the number of endothelial cells, but also the quality of the vasculature play an important role in how chemo- and radiotherapies are delivered to tumour site. Hence in this study a minimally-parametrised mathematical model of endothelial cell proliferation and maturation is developed. Endothelial cells are subdivided into two compartments -- mature and immature (or proliferating). The cells are assumed to undergo a self-mediated maturation, while loss of blood vessel quality is mediated by an external growth factor (here VEGF). The model is fitted to experimental data. The model shows how inhibition of VEGF results in better quality vasculature and slower proliferation.

Keywords: Angiogenesis, mathematical modelling, tumour growth, vascular endothelial growth factor

Subject classification: 92C50; 37N25; 92B05

References

[1] T. Alarcón, H. M. Byrne, and P. K. Maini. Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapys. Computational and Mathematical Methods in Medicine, 7:85-119, 2006. doi: 10.1080/10273660600968994.

[2] J. Folkman. Tumor angiogenesis. therapeutic implications. New England Journal of Medicine, 285:1182-1186, 1971. doi:10.1056/NEJM197111182852108.

[3] P. Hahnfeldt, D. Panigrahy, J. Folkman, and L. Hlatky. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Research, 59: 4770-4775, 1999.

[4] R. Jain. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science, 307:58-62, 2005. doi: 10.1126/science. 1104819.

[5] J. Poleszczuk and I. Skrzypczak. Tumour angiogenesis model with variable vessels' effectiveness. Applicationes Mathematica, 38:33-49, 2011. doi: 10.14708/ma.v41i1.382.

[6] D. Ribatti. Judah Folkman, a pioneer in the study of angiogenesis. Angiogenesis, 11:3-10, 2008. doi: 10.1007/s10456-008-9092-6.

[7] A. Wolfe, B. O'Clair, V. E. Groppi, and D. P. McEwen. Pharmacologic
characterization of a kinetic in vitro human co-culture angiogenesis model using clinically relevant compounds. Journal of Biomolecular Screening, 18:1234-1245, 2013. doi: 10.1177/1087057113502085.



Pages: 3-12

Full Text: PDF


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Creative Commons License
Mathematica Applicanda by Polish Mathematical Society is licensed under a Creative Commons Attribution-ShareAlike 3.0 Unported License.
Based on a work at http://ma.ptm.org.pl/.
Permissions beyond the scope of this license may be available at http://www.ptm.org.pl/.

The journal sponsored by

Ministry of Science and High Education

0.7
2024CiteScore
 
19th percentile
Powered by  Scopus
The journal is abstracted and indexed in:

Matematyka Stosowana. Roczniki Polskiego Towarzystwa Matematycznego. Seria 3. Print(1973-1990) ISSN 0137—2890
Roczniki Polskiego Towarzystwa Matematycznego. Matematyka Stosowana. (Roczniki Polskiego Towarzystwa Matematycznego. Annals of the Polish Mathematical Society. Applied Mathematics) Seria 3. Print(1991-1999) ISSN 0137—2890
,,Matematyka Stosowana: matematyka dla społeczeństwa: pismo Polskiego Towarzystwa Matematycznego" Print(2000-2011) ISSN 1730-2668
Mathematica Applicanda. ISSN 2299-4009 On-line(Since 2012)
0.7
2024CiteScore
 
19th percentile
Powered by  Scopus